Demographic characters and laboratory parameters
The cohort consisted of 239 patients,140 patients met discharge
criteria (58.6%) and 99(41.4%) patients eventually returned to death
(%).Among the patients, 122(51%) were male and 117(49%) were female.
The median age was 57 (39, 71) years. 107 patients were aged ≥60 years
(44.8%). Patients were divided into the improvement group and death
groups according to their final outcomes. The majority of patients had
low and moderate fever, while the remaining patients had high or no
fever. A higher proportion of patients in the improvement group came to
the hospital within 6 days of the onset of symptoms, as opposed to
patients in the death group, who took longer than 6 days from symptom
onset to treatment. The mean age of patients in the death group was
significantly higher than that in the improvement group(70.00±13.53
vs.47.47±16.83 ,p<0.001). Patients in the death group had
higher rates of upper respiratory symptoms(coughing , runny nose, and
sneezing), dyspnea, headache, muscle pain, gastrointestinal
symptoms(vomiting and diarrhea), and comorbidities. There were
statistically significant differences in hypertension, diabetes and
coronary heart disease among the comorbidients. Among clinical symptoms,
there were statistically significant differences in upper respiratory
tract symptoms and dyspnea. The proportion of male in death group was
higher than that in the improvement group, and the difference was
statistically significant. All data of patients with demographic
characters, clinical symptoms and comorbidities were summarized in
Table1.